375 related articles for article (PubMed ID: 28600472)
1. Precision Medicine in Pediatric Oncology: Translating Genomic Discoveries into Optimized Therapies.
Tran TH; Shah AT; Loh ML
Clin Cancer Res; 2017 Sep; 23(18):5329-5338. PubMed ID: 28600472
[TBL] [Abstract][Full Text] [Related]
2. Future of clinical genomics in pediatric oncology.
Janeway KA; Place AE; Kieran MW; Harris MH
J Clin Oncol; 2013 May; 31(15):1893-903. PubMed ID: 23589558
[TBL] [Abstract][Full Text] [Related]
3. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
Mack SC; Northcott PA
J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
[TBL] [Abstract][Full Text] [Related]
4. Precision medicine in pediatric oncology.
Forrest SJ; Geoerger B; Janeway KA
Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
[TBL] [Abstract][Full Text] [Related]
5. Translating genomic discoveries to the clinic in pediatric oncology.
Glade Bender J; Verma A; Schiffman JD
Curr Opin Pediatr; 2015 Feb; 27(1):34-43. PubMed ID: 25502895
[TBL] [Abstract][Full Text] [Related]
6. Precision Oncology Decision Support: Current Approaches and Strategies for the Future.
Kurnit KC; Dumbrava EEI; Litzenburger B; Khotskaya YB; Johnson AM; Yap TA; Rodon J; Zeng J; Shufean MA; Bailey AM; Sánchez NS; Holla V; Mendelsohn J; Shaw KM; Bernstam EV; Mills GB; Meric-Bernstam F
Clin Cancer Res; 2018 Jun; 24(12):2719-2731. PubMed ID: 29420224
[TBL] [Abstract][Full Text] [Related]
7. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities.
Tran TH; Hunger SP
Semin Cancer Biol; 2022 Sep; 84():144-152. PubMed ID: 33197607
[TBL] [Abstract][Full Text] [Related]
8. Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers.
Radovich M; Kiel PJ; Nance SM; Niland EE; Parsley ME; Ferguson ME; Jiang G; Ammakkanavar NR; Einhorn LH; Cheng L; Nassiri M; Davidson DD; Rushing DA; Loehrer PJ; Pili R; Hanna N; Callaghan JT; Skaar TC; Helft PR; Shahda S; O'Neil BH; Schneider BP
Oncotarget; 2016 Aug; 7(35):56491-56500. PubMed ID: 27447854
[TBL] [Abstract][Full Text] [Related]
9. Personalized cancer therapy-leveraging a knowledge base for clinical decision-making.
Dumbrava EI; Meric-Bernstam F
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29212833
[TBL] [Abstract][Full Text] [Related]
10. Future Approaches to Precision Oncology-Based Clinical Trials.
Mittra A; Moscow JA
Cancer J; 2019; 25(4):300-304. PubMed ID: 31335395
[TBL] [Abstract][Full Text] [Related]
11. The era of precision oncogenomics.
Carpten JC; Mardis ER
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29610397
[No Abstract] [Full Text] [Related]
12. Precision oncogenomics in pediatrics: a personal reflection.
Campbell C; Greenfield JP
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29610396
[TBL] [Abstract][Full Text] [Related]
13. Precision oncology based on omics data: The NCT Heidelberg experience.
Horak P; Klink B; Heining C; Gröschel S; Hutter B; Fröhlich M; Uhrig S; Hübschmann D; Schlesner M; Eils R; Richter D; Pfütze K; Geörg C; Meißburger B; Wolf S; Schulz A; Penzel R; Herpel E; Kirchner M; Lier A; Endris V; Singer S; Schirmacher P; Weichert W; Stenzinger A; Schlenk RF; Schröck E; Brors B; von Kalle C; Glimm H; Fröhling S
Int J Cancer; 2017 Sep; 141(5):877-886. PubMed ID: 28597939
[TBL] [Abstract][Full Text] [Related]
14. Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.
McGowan ML; Settersten RA; Juengst ET; Fishman JR
Urol Oncol; 2014 Feb; 32(2):187-92. PubMed ID: 24445286
[TBL] [Abstract][Full Text] [Related]
15. Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.
Tsongalis GJ; Coleman WB
J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S60-S66. PubMed ID: 28921651
[TBL] [Abstract][Full Text] [Related]
16. Defining, Identifying, and Understanding "Exceptional Responders" in Oncology Using the Tools of Precision Medicine.
Tsimberidou AM; Said R; Staudt LM; Conley BA; Takebe N
Cancer J; 2019; 25(4):296-299. PubMed ID: 31335394
[TBL] [Abstract][Full Text] [Related]
17. Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.
Tasian SK; Hunger SP
Br J Haematol; 2017 Mar; 176(6):867-882. PubMed ID: 27984637
[TBL] [Abstract][Full Text] [Related]
18. "Personalized Cancer Therapy": A Publicly Available Precision Oncology Resource.
Kurnit KC; Bailey AM; Zeng J; Johnson AM; Shufean MA; Brusco L; Litzenburger BC; Sánchez NS; Khotskaya YB; Holla V; Simpson A; Mills GB; Mendelsohn J; Bernstam E; Shaw K; Meric-Bernstam F
Cancer Res; 2017 Nov; 77(21):e123-e126. PubMed ID: 29092956
[TBL] [Abstract][Full Text] [Related]
19. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
Janiaud P; Serghiou S; Ioannidis JPA
Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
[TBL] [Abstract][Full Text] [Related]
20. Universal Genomic Testing: The next step in oncological decision-making or a dead end street?
Holch JW; Metzeler KH; Jung A; Riedmann K; Jost PJ; Weichert W; Kirchner T; Heinemann V; Westphalen CB
Eur J Cancer; 2017 Sep; 82():72-79. PubMed ID: 28648701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]